WhiteCoat Fortuna

Selling a practice: valuation, succession, and post-sale planning.

When a doctor decides to sell their clinic or partnership, the decision touches every part of their financial life. The work is more than the deal.

[ Senior Partner ]·24 October 2025·5 min read

Some time in their late fifties or sixties, many senior doctors face a question that, until then, may not have been imagined. Should I sell my practice? The question can come from a number of directions: a corporate hospital chain making an acquisition offer, a younger colleague wanting to buy in, a desire to step back from clinical management, or a planned career transition into purely consulting or academic work.

Selling a practice — whether a single-doctor clinic, a small group, or a partnership — is one of the more complex financial decisions of a doctor's career. The transaction itself is only the visible part. The work around it is broader and longer.

The valuation question

The first hard question is what is the practice worth? Doctor practices are valued differently by different acquirers, and the spread can be wide.

Asset-based valuation — equipment, leasehold improvements, supplies — is the floor. For a typical clinic, this rarely exceeds ₹50 lakh to ₹2 crore.

Earnings-based valuation — typically a multiple of recent average annual EBITDA — is more common and more meaningful. Indian standalone clinics in 2026 typically trade at 2-5x EBITDA, depending on size, specialty, location, and the buyer's strategic interest. Larger groups or specialty chains can trade at higher multiples (5-10x) when acquired by a corporate hospital with a strategic interest.

Goodwill or brand-based valuation — the value attached to the doctor's name, patient base, and continued involvement — is sometimes layered on top, particularly when the acquirer wants the doctor to continue practising under the new structure.

The complication is that most of the practice's value, in most cases, is tied to the doctor's continued presence. If the doctor sells and walks away, the value drops materially. If the doctor sells with a structured continued-engagement, the value sustains and the doctor receives a higher transaction value plus continued income for some years.

The structural choice — sell vs. transition

Beyond the price, the transaction has structural variants that are worth understanding before committing.

Outright sale. The doctor sells, walks away within an agreed transition period, and moves on. Cleanest for the doctor. Lowest valuation for the practice.

Phased sale with continued involvement. The doctor sells a controlling stake, retains a meaningful minority interest, and continues to practice under the new structure for 3-7 years before fully exiting. Higher valuation, more complexity, longer transition.

Earn-out structure. Part of the purchase price is paid upfront; part is contingent on practice performance over a defined period. Common in chain acquisitions, less common in single-doctor sales but increasingly used in larger group transactions.

Internal succession. The practice is sold to a junior partner or group of partners over time. Often produces a lower headline price than a corporate sale, but with greater alignment, lower transition risk, and frequently better tax treatment.

The choice depends on the doctor's age, energy for transition, financial needs, and emotional readiness to step away. None is universally better.

What happens after the sale

The transaction itself is a moment. The financial life that follows is several decades. We see most doctors give 80% of their attention to the transaction and 20% to the post-sale plan; the better split is the reverse.

Post-sale planning has three large components.

1. Tax structuring of the proceeds. A practice sale is typically a substantial capital event. Where the transaction is in the doctor's personal name, the gains are taxed as long-term capital gains (15-25% depending on classification and current law). Where structured through an LLP or partnership, different treatments may apply. Pre-transaction structuring can materially reduce the tax leakage.

2. Deployment plan for the proceeds. A lump-sum receipt of ₹10-30 crore (typical range for senior clinic sales) is a different financial situation than the doctor has ever faced. Deploying it requires a clear plan, ideally agreed before the proceeds arrive. The default — letting it sit in current accounts while figuring out what to do — is common and costly. We typically design a 18-36 month deployment plan that staggers the placement across asset classes, rather than producing a single deployment moment.

3. Income replacement architecture. The practice produced ongoing income. Post-sale, the doctor may have a partial continued income (consulting, teaching, light clinical practice) but the structural income from the practice is gone. The deployment plan must replace it, usually through a combination of yield-bearing investments, structured drawdowns, and where applicable, partial income from continued involvement.

The pre-transaction work

In our practice, the pre-transaction work begins 12-24 months before the sale closes. It includes:

  • Practice valuation modelling, run by a specialist with comparable transactions.
  • Tax structuring review — entity choice, gain classification, family-trust vehicles for proceeds.
  • Deployment plan, designed assuming the transaction closes.
  • Income-replacement modelling for the post-sale years.
  • Family conversation about the transition — what changes, what doesn't, what the doctor will do with the new shape of life.
  • Engagement of legal counsel specialised in healthcare transactions.

The work is mostly about not being surprised by the post-sale reality. Most doctors who have sold their practice without this preparation describe the first six post-sale months as harder than they expected. Most who have done the preparation describe the transition as the cleanest they could have imagined.

When not to sell

Equally important is the doctor's clear understanding of when the offer should be declined.

  • When the offer values the practice at less than 70-80% of a credible benchmark valuation.
  • When the doctor has not yet found what they want to do with the next chapter of their life — the sale will then produce restlessness.
  • When the family financial plan does not actually need the proceeds to function — i.e., the sale would be a want, not a need, and the practice itself is producing acceptable income.
  • When the buyer's structure or culture is materially different from the doctor's, in ways that will create regret post-sale (e.g., a corporate chain that will reduce time-per-patient and conflict with the doctor's values).

We have walked alongside doctors who declined offers that, on the surface, seemed attractive — and were, on examination, not the right transaction at the right time. The decline is sometimes the right answer. The advisor's role is to help the doctor see the question fully before answering it.

The plain version

Selling a practice is a once-in-a-career decision. The transaction is one moment in a much longer financial and emotional process. The work that surrounds it — the valuation discipline, the structural planning, the deployment design, the personal preparation — is what determines whether the sale is the right sale, executed well. Most doctors get one chance at it. Done thoughtfully, it sets the family's financial life for the next thirty years. Done casually, it leaves money on the table and the doctor in an unstructured post-sale life that takes years to settle into.

Written by
[ Senior Partner ]
Partner, WhiteCoat Fortuna
Receive new notes by email

We send only when there's something worth saying — typically once or twice a month.

A short note is all it takes to start.

First conversations are always with a senior partner — without obligation, without product, and without a clock running.